Irbesartan and Hydrochlorothiazide (Lupin Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the Irbesartan and Hydrochlorothiazide drug offered from Lupin Pharmaceuticals, Inc.. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Lupin Pharmaceuticals, Inc. |
| NON-PROPRIETARY NAME: | Irbesartan and Hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-04-04 |
| END MARKETING DATE: | 0000-00-00 |
Irbesartan and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irbesartan and Hydrochlorothiazide from Lupin Pharmaceuticals, Inc. |
| LABELER NAME: | Lupin Pharmaceuticals, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 150(mg/1; mg/1) |
| START MARKETING DATE: | 2013-04-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68180-413_d7b3392d-532c-4c81-badd-f61c89cf5244 |
| PRODUCT NDC: | 68180-413 |
| APPLICATION NUMBER: | ANDA201524 |
Other HYDROCHLOROTHIAZIDE; IRBESARTAN Pharmaceutical Manufacturers / Labelers:
